HomeOpen Access NewsClinical Trials

Clinical Trials

First human trial of regenerative cell therapy for sensorineural hearing loss approved

The University of Sheffield announces approval of the first human trial testing regenerative cell therapy to treat sensorineural hearing loss, offering hope for restoring hearing function.

Is fusobacterium responsible for the formation of endometriosis?

Fusobacterium, implicated in diseases like gingivitis, ulcerative colitis, and colon cancer, has now been discovered to play a role in the formation of endometriosis.

Phasing out the use of animals in science

Barney Reed, Senior Scientific Manager, Animals in Science Department at the RSPCA, stresses the need for ambitious strategies for phasing out the use of animals in science.

Phasing out the use of animals in science

Barney Reed, Senior Scientific Manager, Animals in Science Department at the RSPCA, stresses the need for ambitious strategies for phasing out the use of animals in science.

“No child should be going blind from ROP”: AI as a solution to childhood blindness

A revolutionary AI tool can predict retinopathy of prematurity (ROP), paving the way for the prevention of childhood blindness.

The Clinical Pathway DevOps Platform to help NHS staff efficiency

Nathan Moore, Director at Primum Digital Ltd looks toward helping NHS staff deliver the best care at a reduced carbon cost.

Gender gaps in drug trials harm women’s health through overmedication

When conducting drug trials, it is vital to include women and men in research to prevent gender gap issues like adverse drug reactions.

Talking therapy for self-harm trial “could make a huge difference”

The National Institute for Health and Care Research (NIHR) launches a new talking therapy for self-harm trial in an effort to reduce the number of those struggling in the UK.

Research, innovation and health inequalities of blood transfusion

Open Access Government investigates the rudiments of blood transfusion, focussing on research in the field and health inequalities.

Long COVID lessons learned beyond the pandemic

The Long COVID lessons learned beyond the COVID-19 pandemic are detailed here by leading Professors working on the University College London STIMULATE-ICP programme.

Tuberculosis drug regimens and their efficacies

Andrew Nunn, Professor of Epidemiology in the Medical Research Council Clinical Trials Unit at UCL, analyses different tuberculosis drug development regimens.

Secure remote healthcare collaboration

Remote healthcare communication tools can be highly effective and useful for collaboration, clinical assessments, and surgical training, finds Ingo Aicher, Managing Director at Jones AV Limited.

Universal flu vaccine trial opens at NIH Clinical Center

A Phase 1 clinical trial of a universal flu vaccine has started inoculating healthy adult volunteers at the National Institutes of Health Clinical Center in Maryland.

Lager beer can lessen risk of disease in men’s gut microbes

Both alcoholic and non-alcoholic lager beer drank in moderation can improve gut microbes in men ­– lessening the chances of developing chronic diseases.

Imaging & radiation oncology core: Improving radiotherapy quality & care

The Imaging and Radiation Oncology Core is part of the U.S. National Cancer Institute’s clinical trial program and provides quality assurance for trials with radiation oncology and/or imaging.

Safer and faster recovery to be expected from robot-assisted surgery

Robot-assisted surgery cut hospital recovery time down by 20%, according to a clinical trial used to perform bladder cancer removal.

NIH begins clinical trial for Epstein-Barr virus vaccine

The clinical trial will test an Epstein-Barr virus vaccine developed by Novavax, one of just two attempts in over a decade.

Advertisements


Latest Academic Articles

The latest academic articles from key research stakeholders